Neose is using its GlycoAdvance and GlycoPEGylation technologies to develop proprietary drug candidates, as well as to partner with biotech and pharmaceutical companies. Their primary focus is developing next generation therapeutic proteins that are improved versions of currently marketed proteins with proven efficacy.